Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $8,400 - $51,251
-34 Reduced 46.58%
39 $10,000
Q3 2021

Oct 21, 2021

SELL
$272.21 - $332.43 $2,722 - $3,324
-10 Reduced 12.05%
73 $22,000
Q2 2021

Jul 26, 2021

SELL
$225.08 - $271.69 $9,678 - $11,682
-43 Reduced 34.13%
83 $22,000
Q1 2021

May 03, 2021

BUY
$212.38 - $245.9 $11,256 - $13,032
53 Added 72.6%
126 $28,000
Q4 2020

Jan 20, 2021

SELL
$212.5 - $245.46 $2,762 - $3,190
-13 Reduced 15.12%
73 $16,000
Q3 2020

Oct 19, 2020

BUY
$177.16 - $215.33 $5,137 - $6,244
29 Added 50.88%
86 $18,000
Q1 2020

Apr 17, 2020

BUY
$121.39 - $169.05 $2,791 - $3,888
23 Added 67.65%
57 $7,000
Q3 2019

Oct 09, 2019

BUY
$135.4 - $146.47 $4,603 - $4,979
34 New
34 $4,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $173B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Ellis Investment Partners, LLC Portfolio

Follow Ellis Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellis Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ellis Investment Partners, LLC with notifications on news.